These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31823010)

  • 1. Peroxisome proliferator-activated receptor ɑ (PPARɑ)-cytochrome P450 epoxygenases-soluble epoxide hydrolase axis in ER + PR + HER2- breast cancer.
    Tauber Z; Koleckova M; Cizkova K
    Med Mol Morphol; 2020 Sep; 53(3):141-148. PubMed ID: 31823010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner.
    Cizkova K
    Toxicol Appl Pharmacol; 2018 Sep; 355():156-163. PubMed ID: 29960002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
    Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
    Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
    Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
    BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
    Fang X; Hu S; Xu B; Snyder GD; Harmon S; Yao J; Liu Y; Sangras B; Falck JR; Weintraub NL; Spector AA
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H55-63. PubMed ID: 16113065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrates Affect Levels of Phosphorylated p38 in Intestinal Cells in a Differentiation-Dependent Manner.
    Cizkova K; Tauber Z
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta.
    Cizkova K; Tauber Z
    Acta Histochem; 2018 Aug; 120(6):513-519. PubMed ID: 29908721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation.
    Chang NW; Wu CT; Chen DR; Yeh CY; Lin C
    J Nutr Biochem; 2013 Jan; 24(1):274-81. PubMed ID: 22902323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic Diseases.
    Xu X; Li R; Chen G; Hoopes SL; Zeldin DC; Wang DW
    Adv Nutr; 2016 Nov; 7(6):1122-1128. PubMed ID: 28140329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors.
    Fang X; Hu S; Watanabe T; Weintraub NL; Snyder GD; Yao J; Liu Y; Shyy JY; Hammock BD; Spector AA
    J Pharmacol Exp Ther; 2005 Jul; 314(1):260-70. PubMed ID: 15798002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.
    Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Epoxide Hydrolase as a Potential Key Factor for Human Prenatal Development.
    Cizkova K; Rajdova A; Ehrmann J
    Cells Tissues Organs; 2016; 201(4):277-86. PubMed ID: 27144772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.
    Deng Y; Theken KN; Lee CR
    J Mol Cell Cardiol; 2010 Feb; 48(2):331-41. PubMed ID: 19891972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
    Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
    Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WY-14643 Regulates CYP1B1 Expression through Peroxisome Proliferator-Activated Receptor α-Mediated Signaling in Human Breast Cancer Cells.
    Hwang YP; Won SS; Jin SW; Lee GH; Pham TH; Choi JH; Kang KW; Jeong HG
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of epoxyeicosatrienoic acids on cellular function.
    Spector AA; Norris AW
    Am J Physiol Cell Physiol; 2007 Mar; 292(3):C996-1012. PubMed ID: 16987999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor alpha-dependent repression of cyclin D1.
    Ng VY; Morisseau C; Falck JR; Hammock BD; Kroetz DL
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2462-8. PubMed ID: 16917105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased epoxyeicosatrienoic acids may be part of a protective mechanism in human ulcerative colitis, with increased CYP2J2 and reduced soluble epoxide hydrolase expression.
    Qiu YE; Qin J; Luo Y; Qin SL; Mu YF; Cun R; Jiang HL; Chen JJ; Yu MH; Zhong M
    Prostaglandins Other Lipid Mediat; 2018 May; 136():9-14. PubMed ID: 29580941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation.
    Fleming I
    Trends Pharmacol Sci; 2007 Sep; 28(9):448-52. PubMed ID: 17764757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisomal proliferator-activated receptor-alpha-dependent inhibition of endothelial cell proliferation and tumorigenesis.
    Pozzi A; Ibanez MR; Gatica AE; Yang S; Wei S; Mei S; Falck JR; Capdevila JH
    J Biol Chem; 2007 Jun; 282(24):17685-95. PubMed ID: 17405874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.